| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $8.4M | +218.6% |
| Cost of Revenue | $6.9M | +224.2% |
| Gross Profit | $1.5M | +195.2% |
| R&D Expense | $157K | +721.3% |
| SG&A Expense | $6.1M | +114.5% |
| Operating Income | -$4.7M | -101.8% |
| Income Tax | $0 | — |
| Net Income | -$5.0M | -118.6% |
| EPS (Basic) | -$0.15 |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $795K | -19.4% |
| Accounts Receivable | $3.0M | +65.2% |
| Inventory | $2.1M | +19.6% |
| Current Assets | $6.7M | +43.1% |
| Total Assets | $6.8M | +46.1% |
| Current Liabilities | $3.5M | +5647.8% |
| Total Liabilities | $3.9M | +6275.5% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.4M | -335.5% |
| Financing Cash Flow | $4.2M | — |
| -114.3% |
| EPS (Diluted) | -$0.15 | -114.3% |
| Stockholders' Equity |
| $2.9M |
| -36.7% |